{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:43:52Z","timestamp":1790520232542,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T00:00:00Z","timestamp":1481760000000},"content-version":"vor","delay-in-days":2509,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1111\/j.1477-2574.2009.00119.x","type":"journal-article","created":{"date-parts":[[2010,8,17]],"date-time":"2010-08-17T10:33:55Z","timestamp":1282041235000},"page":"37-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis"],"prefix":"10.1016","volume":"12","author":[{"given":"Prosanto","family":"Chaudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Hassanain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Bouganim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Kavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Metrakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0010","series-title":"Cancer Facts & Figures 2008","author":"American Cancer Society","year":"2008"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0015","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/bjs.1800771115","article-title":"Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history","volume":"77","author":"Scheele","year":"1990","journal-title":"Brit J Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0020","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/annonc\/mdg404","article-title":"Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial)","volume":"14","author":"Zelek","year":"2003","journal-title":"Annal Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.sla.0000138076.72547.b1","article-title":"Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET)","volume":"240","author":"Fernandez","year":"2004","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","article-title":"Trends in longterm survival following liver resection for hepatic colorectal metastases","volume":"235","author":"Choti","year":"2002","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0035","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.sla.0000160703.75808.7d","article-title":"Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases","volume":"241","author":"Pawlik","year":"2005","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0040","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"De Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000658-199610000-00009","article-title":"Resection of non-resectable liver metastases from colorectal cancer after neoadjuvant chemotherapy","volume":"224","author":"Bismuth","year":"1996","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0050","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict longterm survival","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0055","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomized controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0060","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0065","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.gassur.2003.08.005","article-title":"Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy","volume":"7","author":"Parikh","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0070","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome endpoint after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0075","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0080","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0085","doi-asserted-by":"crossref","first-page":"5254","DOI":"10.1200\/JCO.2008.17.7857","article-title":"Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases","volume":"26","author":"Kesmodel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0090","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1245\/s10434-006-9074-0","article-title":"Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study","volume":"14","author":"D'Angelica","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jamcollsurg.2007.06.290","article-title":"Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases","volume":"206","author":"Reddy","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0100","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2007.13.7679","article-title":"Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer","volume":"26","author":"Gruenberger","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for non-alcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/gut.2004.046524","article-title":"The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection","volume":"54","author":"Schindl","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.sla.0000205826.62911.a7","article-title":"The adaptive response of the reticuloendothelial system to major liver resection in humans","volume":"243","author":"Schindl","year":"2006","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0130","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1245\/s10434-006-9337-9","article-title":"Gastrointestinal perforation due to bevacizumab in colorectal cancer","volume":"14","author":"Saif","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","article-title":"Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases","volume":"94","author":"Zorzi","year":"2007","journal-title":"Br J Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0140","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/jso.20632","article-title":"Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect perioperative outcomes","volume":"95","author":"Sahajpal","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.gassur.2006.01.002","article-title":"Postchemotherapy characteristics of hepatic colorectal metastases: remnants of uncertain malignant potential","volume":"10","author":"Znajda","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1111\/j.1477-2574.2009.00119.x_bb0160","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/annonc\/mdl161","article-title":"A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200","volume":"17","author":"Giantonio","year":"2006","journal-title":"Ann Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X1530246X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X1530246X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:53:39Z","timestamp":1761263619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X1530246X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1365182X1530246X"],"URL":"https:\/\/doi.org\/10.1111\/j.1477-2574.2009.00119.x","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1477-2574.2009.00119.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Hepato-Pancreato-Biliary Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}